New Delhi [India], June 3 (ANI): A Fresh application was moved in Delhi High Court on Thursday seeking to stay the operation of the order of Drugs Controller General of India (DCGI) for conducting phase II/III clinical trials of Whole Virion Inactivated Coronavirus Vaccine in the 2 to 18 yea
Patna (Bihar) [India], June 3 (ANI): Patna's All India Institute of Medical Sciences (AIIMS) has started the paediatric trials for the COVID-19 vaccine manufactured by the Bharat Biotech, Covaxin.
New Delhi [India], June 2 (ANI): The Supreme Court on Wednesday directed the Central government to submit complete data on its purchase history along with administration of doses of all the COVID-19 vaccines-- Covaxin, Covishield and Sputnik V-- till date.
Mumbai (Maharashtra) [India], June 2 (ANI): Haffkine Bio-Pharmaceutical Corporation Limited (HBPCL), a Maharashtra government undertaking, is preparing for mass production of Covaxin and will have capacity to produce over 22 crore doses of the COVID-19 vaccine every year once the requisit
New Delhi [India], June 1 (ANI): The Government of India on Tuesday clarified that mixing of COVID-19 vaccines is not protocol yet and asserted there is no change in the schedule of two-dose vaccines Covishield and Covaxin.
New Delhi [India], May 31 (ANI): Delhi is left with 3,190 COVID vaccine doses in its balance stock out of which 1,120 doses are of Covaxin and 2,070 of Covishield reserved for the age group 18-44 years, informed the Delhi government.
New Delhi [India], May 31 (ANI): With ramping up of production capacities, nearly 25 crore ‘Made in India’ vaccine doses are expected to be available by August, a senior official has said and noted that it will go a long way in meeting the target of vaccinating one crore peopl
New Delhi [India], May 29 (ANI): Delhi received a fresh stock of COVID-19 vaccine that includes 48,890 doses of Covaxin and 83,970 doses of Covishield from the Centre, said Aam Aadmi Party (AAP) MLA Atishi on Saturday.
New Delhi [India], May 28 (ANI): Amid reports of shortage of its COVID-19 vaccine in the country, Bharat Biotech on Friday said that the timeline for manufacturing, testing, and release for a batch of Covaxin is approximately 120 days, depending on the technology framework and regulatory
Hyderabad (Telangana) [India], May 28 (ANI): Indian Immunologicals Limited (IIL) has partnered with Hyderabad-based Bharat Biotech to manufacture drug substance for 'Covaxin' to ramp up the production of the COVID-19 vaccine.
New Delhi [India], May 28 (ANI): Administering two different COVID-19 vaccines, specially those with similar underlying platform, is still under research and supply constraints have to be resolved so that people can take their vaccine doses on time, experts have said.
New Delhi [India], May 27 (ANI): A drive-through COVID-19 vaccination centre has been set for all eligible beneficiaries above 18 years of age at Saket's Select City Walk mall in south Delhi.